Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases

The H1 haplotype of the 17q21.31 inversion polymorphism has been consistently associated with progressive supranuclear palsy, corticobasal degeneration, and Parkinson's disease in Caucasians. Recently, large polymorphic segmental duplications resulting into complex rearrangements at this locus...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of medical genetics. Part B, Neuropsychiatric genetics Vol. 171B; no. 2; pp. 175 - 180
Main Authors Cervera-Carles, Laura, Pagonabarraga, Javier, Pascual-Sedano, Berta, Pastor, Pau, Campolongo, Antonia, Fortea, Juan, Blesa, Rafael, Alcolea, Daniel, Morenas-Rodríguez, Estrella, Sala, Isabel, Lleó, Alberto, Kulisevsky, Jaime, Clarimón, Jordi
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.03.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1552-4841
1552-485X
1552-485X
DOI10.1002/ajmg.b.32390

Cover

More Information
Summary:The H1 haplotype of the 17q21.31 inversion polymorphism has been consistently associated with progressive supranuclear palsy, corticobasal degeneration, and Parkinson's disease in Caucasians. Recently, large polymorphic segmental duplications resulting into complex rearrangements at this locus with a high diversity range in human populations have been revealed. We sought to explore whether the two multi‐allelic copy number variants that are present in the H1 clade (with segmental duplications of 300 and 218 kilobases in length) could be responsible for the known H1‐related risk of developing these neurodegenerative disorders. A total of 857 Spanish subjects including 330 patients with Parkinson's disease, 96 with progressive supranuclear palsy, 55 with corticobasal degeneration, 51 dementia with Lewy bodies, and 325 neurologically healthy controls, were genotyped for the H1/H2 haplotype. Subsequently, the two copy number variants that are characteristic of the H1 haplotype were evaluated through a high‐resolution approach based on droplet digital polymerase chain reaction, in all H1 homozygous subjects. The H1 allele was significantly overrepresented in all diagnostic groups compared with controls (Parkinson's disease, P = 0.0001; progressive supranuclear palsy, P = 1.22 × 10−6; corticobasal degeneration, P = 0.0002; and dementia with Lewy bodies, P = 0.032). However, no dosage differences were found for any of the two copy number variants analyzed. The H1 haplotype is associated with the risk of several neurodegenerative disorders, including dementia with Lewy bodies. However, common structural diversity within the 17q21.31‐H1 clade does not explain this genetic association. © 2015 Wiley Periodicals, Inc.
Bibliography:ark:/67375/WNG-K6NHMC70-T
ArticleID:AJMGB32390
istex:4EFB6A36D076633096FBF14087721002A2B87E68
Spanish Ministry of Science and Innovation - No. SAF2006-10126 (2006-2009); No. SAF2010-22329-C02-01 (2010-2012); No. SAF2013-47939-R (2013-2015)
Instituto de Salud Carlos III - No. PI12/01311
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1552-4841
1552-485X
1552-485X
DOI:10.1002/ajmg.b.32390